AAAAAA

   
Results: 1-14 |
Results: 14

Authors: Bleyer, AJ Donaldson, LA McIntosh, M Adams, PL
Citation: Aj. Bleyer et al., Relationship between underlying renal disease and renal transplantation outcome, AM J KIDNEY, 37(6), 2001, pp. 1152-1161

Authors: Bleyer, AJ White, WL Choi, MJ
Citation: Aj. Bleyer et al., Calcific small vessel ischemic disease (calciphylaxis) in dialysis patients, INT J ARTIF, 23(6), 2000, pp. 351-355

Authors: Bleyer, AJ Burke, S Slatopolsky, E
Citation: Aj. Bleyer et al., Untitled - In reply, AM J KIDNEY, 35(6), 2000, pp. 1249-1250

Authors: Bleyer, AJ Shemanski, LR Burke, GL Hansen, KJ Appel, RG
Citation: Aj. Bleyer et al., Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population, KIDNEY INT, 57(5), 2000, pp. 2072-2079

Authors: Bleyer, AJ Burkart, JM Russell, GB Adams, PL
Citation: Aj. Bleyer et al., Dialysis modality and delayed graft function after cadaveric renal transplantation, J AM S NEPH, 10(1), 1999, pp. 154-159

Authors: Satko, SG Burkart, JM Bleyer, AJ Jordan, JR Manning, T
Citation: Sg. Satko et al., Frequency and causes of discrepancy between Kt/V and creatinine clearance, PERIT DIA I, 19(1), 1999, pp. 31-37

Authors: Appel, RG Bleyer, AJ
Citation: Rg. Appel et Aj. Bleyer, Pica associated with renal and electrolyte disorders, INT J ARTIF, 22(11), 1999, pp. 726-729

Authors: Chertow, GM Dillon, M Burke, SK Steg, M Bleyer, AJ Garrett, BN Domoto, DT Wilkes, BM Wombolt, DG Slatopolsky, E
Citation: Gm. Chertow et al., A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium - Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients, CLIN NEPHR, 51(1), 1999, pp. 18-26

Authors: Bleyer, AJ
Citation: Aj. Bleyer, A reciprocal graph to plot the reciprocal serum creatinine over time, AM J KIDNEY, 34(3), 1999, pp. 576-578

Authors: Bleyer, AJ Burke, SK Dillon, M Garrett, B Kant, KS Lynch, D Rahman, SN Schoenfeld, P Teitelbaum, I Zeig, S Slatopolsky, E
Citation: Aj. Bleyer et al., A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients, AM J KIDNEY, 33(4), 1999, pp. 694-701

Authors: Perry, JJ Fleming, RA Rocco, MV Petros, WP Bleyer, AJ Radford, JE Powell, BL Hurd, DD
Citation: Jj. Perry et al., Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease, BONE MAR TR, 23(8), 1999, pp. 839-842

Authors: Bleyer, AJ Hylander, B Sudo, H Nomoto, Y de la Torre, E Chen, RA Burkart, JM
Citation: Aj. Bleyer et al., An international study of patient compliance with hemodialysis, J AM MED A, 281(13), 1999, pp. 1211-1213

Authors: Bleyer, AJ Russell, GB Satko, SG
Citation: Aj. Bleyer et al., Sudden and cardiac death rates in hemodialysis patients, KIDNEY INT, 55(4), 1999, pp. 1553-1559

Authors: Bleyer, AJ Appel, RG
Citation: Aj. Bleyer et Rg. Appel, Risk factors associated with hypertensive nephrosclerosis, NEPHRON, 82(3), 1999, pp. 193-198
Risultati: 1-14 |